This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Relationship: 683

Title

A descriptive phrase which clearly defines the two KEs being considered and the sequential relationship between them (i.e., which is upstream, and which is downstream). More help

Reduction, Neuronal synaptic inhibition leads to Generation, Amplified excitatory postsynaptic potential (EPSP)

Upstream event
The causing Key Event (KE) in a Key Event Relationship (KER). More help
Downstream event
The responding Key Event (KE) in a Key Event Relationship (KER). More help

Key Event Relationship Overview

The utility of AOPs for regulatory application is defined, to a large extent, by the confidence and precision with which they facilitate extrapolation of data measured at low levels of biological organisation to predicted outcomes at higher levels of organisation and the extent to which they can link biological effect measurements to their specific causes.Within the AOP framework, the predictive relationships that facilitate extrapolation are represented by the KERs. Consequently, the overall WoE for an AOP is a reflection in part, of the level of confidence in the underlying series of KERs it encompasses. Therefore, describing the KERs in an AOP involves assembling and organising the types of information and evidence that defines the scientific basis for inferring the probable change in, or state of, a downstream KE from the known or measured state of an upstream KE. More help

AOPs Referencing Relationship

AOP Name Adjacency Weight of Evidence Quantitative Understanding Point of Contact Author Status OECD Status
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain adjacent High Moderate Cataia Ives (send email) Open for citation & comment WPHA/WNT Endorsed

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KER.In general, this will be dictated by the more restrictive of the two KEs being linked together by the KER.  More help
Term Scientific Term Evidence Link
rat Rattus norvegicus High NCBI
human Homo sapiens High NCBI

Sex Applicability

An indication of the the relevant sex for this KER. More help

Life Stage Applicability

An indication of the the relevant life stage(s) for this KER.  More help

Key Event Relationship Description

Provides a concise overview of the information given below as well as addressing details that aren’t inherent in the description of the KEs themselves. More help

GABAA receptors mediate two distinct forms of inhibition, phasic and tonic. The first consists of fast inhibitory postsynaptic potentials (IPSPs), regulating point-to-point communication between neurons. The second consists of a persistent inhibitory conductance that plays a crucial role in regulating the membrane potential and network excitability (Farrant and Nusser 2005). In the case of phasic inhibition, synaptic GABAA receptors, facing presynaptic release sites, are activated by a brief exposure to a high concentration of GABA released by exocytosis of presynaptic vesicles. Once released, GABA diffuses throughout the neuropil before being taken up by selective plasma membrane transporters, which contribute to the clearance of the neurotransmitter (Cherubini and Conti 2001). In the case of tonic inhibition, extrasynaptic GABAA receptors, localized away from the synapses, are persistently exposed to low concentration of “ambient” GABA.

Fast inhibitory neurotransmission in the mammalian central nervous system (CNS) is mediated primarily by the neurotransmitters GABA and glycine. Glycine is predominantly used in the spinal cord and the brain stem, whereas GABA is more commonly used in the brain (Jentsch et al. 2002). As the dominant charge carrier through GABA-A receptors, chloride is directly implicated in the efficacy of fast neuronal synaptic inhibition (Prescott 2014). The binding of GABA to GABAA receptors opens intrinsic anion channels, which leads to a Cl influx that hyperpolarizes the neuron and thereby inhibits postsynaptic neuronal activity in the adult CNS (Jentsch et al. 2002). Neurons communicate through action potentials along their axons, and those action potentials are electrical events that depend on the movements of ions, particularly sodium and potassium, across the neuronal cell membrane (Jefferys 2010). Postsynaptic conductance changes and the potential changes that accompany them alter the probability that an action potential will be produced in the postsynaptic cell. Postsynaptic potentials (PSPs) are called excitatory (or EPSPs) if they increase the likelihood of a postsynaptic action potential occurring, and inhibitory (or IPSPs) if they decrease this likelihood (Purves et al. 2001). Given that most neurons receive inputs from both excitatory and inhibitory synapses, it is important to understand more precisely the mechanisms that determine whether a particular synapse excites or inhibits its postsynaptic partner. In order to generate large EPSPs underlying depolarization shift (cause of interictal spike discharge or epileptic seizure), the normal small EPSPs must be amplified (Dichter and Ayala 1987). Blocking of chloride channel by non-competitive blockers at the picrotoxin convulsant site on GABAA receptors reduces IPSPs or increases the probability of firing of the neuron, causing an enhancement of excitatory postsynaptic action potentials (EPSPs) (Dichter and Ayala 1987).

Evidence Collection Strategy

Include a description of the approach for identification and assembly of the evidence base for the KER. For evidence identification, include, for example, a description of the sources and dates of information consulted including expert knowledge, databases searched and associated search terms/strings.  Include also a description of study screening criteria and methodology, study quality assessment considerations, the data extraction strategy and links to any repositories/databases of relevant references.Tabular summaries and links to relevant supporting documentation are encouraged, wherever possible. More help

Evidence Map 2.0

ID Experimental Design Species Upstream Observation Downstream Observation Citation (first author, year) Notes

Evidence Map

Addresses the scientific evidence supporting KERs in an AOP setting the stage for overall assessment of the AOP. More help
Title First Author
Biological Plausibility
Dose Concordance
Temporal Concordance
Incidence Concordance
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
Addresses inconsistencies or uncertainties in the relationship including the identification of experimental details that may explain apparent deviations from the expected patterns of concordance. More help

A synapse involves three compartments: the presynaptic terminal, the postsynaptic site, and the glial cell processes surrounding them. Many features of the synapse can be modified. The number of synapses established by a given neuron on its targets can decrease (“pruning” or death of the presynaptic neuron) or increase (sprouting, neosynaptogenesis). The properties of the presynaptic terminal can be changed (release probability, neurotransmitter concentration in vesicles, control by presynaptic receptors). On the postsynaptic site, the number, subunit composition, and function (e.g., phosphorylation, anchoring) of the receptors can be changed. Finally, alterations at the glial cell level may affect the environment of the synapse and its function (neurotransmitter uptake, energy supply to neurons, etc.). See Bernard (2012) for a detailed review on the state of our current knowledge regarding the time-dependent reorganizations of GABAergic circuits at the synaptic level during epileptogenesis and a discussion on the possible functional consequences of these alterations (particularly on the fate of GABAergic circuits).

With respect to the cause of EPSP amplification, there exist at least four mechanisms other than the withdrawal or reduction of inhibition in the epileptic foci of normal CNS (Dichter and Ayala 1987): (i) frequency potentiation of EPSPs, (ii) changes in the space constant of the dendrites (or spines) of the postsynaptic neuron, (iii) activation of the NMDA receptor as the cell depolarizes as a result of a reduction in voltage-dependent block of the receptor by Mg2+, and (iv) potentiation by neuromodulators that are released during the ID (for example, norepinephrine, somatostatin, and acetylcholine). In addition to direct increases in excitatory synaptic efficacy, the depolarizing effects of EPSPs can be supplemented by several voltage-dependent intrinsic currents that exist in CNS neurons. These include slowly inactivating Na+ and Ca2+ currents and a large, transient Ca2+ current that is likely to be responsible for Ca2+-dependent action potentials.

The above synaptic modifications and diverse causes of EPSP amplification constitute the uncertainty factors for the relationship between reduced IPSPs and amplification of EPSPs at the affected GABAergic neurons.

Known modulating factors

This table captures specific information on the MF, its properties, how it affects the KER and respective references.1.) What is the modulating factor? Name the factor for which solid evidence exists that it influences this KER. Examples: age, sex, genotype, diet 2.) Details of this modulating factor. Specify which features of this MF are relevant for this KER. Examples: a specific age range or a specific biological age (defined by...); a specific gene mutation or variant, a specific nutrient (deficit or surplus); a sex-specific homone; a certain threshold value (e.g. serum levels of a chemical above...) 3.) Description of how this modulating factor affects this KER. Describe the provable modification of the KER (also quantitatively, if known). Examples: increase or decrease of the magnitude of effect (by a factor of...); change of the time-course of the effect (onset delay by...); alteration of the probability of the effect; increase or decrease of the sensitivity of the downstream effect (by a factor of...) 4.) Provision of supporting scientific evidence for an effect of this MF on this KER. Give a list of references.  More help

Domain of Applicability

A free-text section of the KER description that the developers can use to explain their rationale for the taxonomic, life stage, or sex applicability structured terms. More help

El-Hassar et al. (2007) and Li et al. (1999) provided evidence for rat whereas Bartolomei et al. (2008) reported evidence for human.